Company intelligence / Profile preview

Tres Cantos Open Lab Foundation

Guildford, Surrey, United Kingdom

Ownership: Private
Development stage: Other

Overview

Tres Cantos Open Lab Foundation is a UK charity that funds and supports early-stage discovery through preclinical and some early clinical development projects for endemic infectious diseases of the developing world in collaboration with GSK’s Tres Cantos R&D campus, but it does not itself own a defined therapeutic pipeline.[1][3][6]

Therapeutic areas: Infectious Diseases
Modalities: Small moleculeVaccineBiologic
Industry: Academic Hospital/University/Research

Partnerships

GSKMedicines for Malaria VentureTuberculosis Drug AcceleratorUS National Institutes of HealthiThemba PharmaceuticalsHarvard Medical SchoolUniversity of OxfordUniversity of DundeeWellcome Trust Sanger InstituteSeattle Biomedical Research Institute

Beyond the preview

Go deeper on Tres Cantos Open Lab Foundation.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Tres Cantos Open Lab Foundation.

Explore the full profile